Home > Blog > Success in rna therapies

Bold Thinking that Delivers Results for RNA Therapies

Success Stories Regulatory Submissions COVID-19 Biologics Full-Service

Current advances in RNA-based therapies hold substantial promise in treating and preventing many human diseases and disorders through curing the disease, rather than treating the symptomology like traditional therapeutics.

While many RNA therapeutics have made it to clinical trials, only a few have been approved. Veristat’s team of scientific-minded experts
have worked on over 60 RNA programs, including several approvedveristat therapeutic centers of excellence therapies. Our experience expands across the clinical development pathway in a broad range of therapeutic areas.

In this piece, learn how Veristat has supported some of our Biotech Sponsors in advancing their RNA therapeutics, including:
  • A landmark RNA approval
  • Navigating a full-service COVID-19 vaccine trial
  • Ensuring a Successful Regulatory Agency Interaction

DOWNLOAD NOW

 

Meet Veristat. Learn More.


 

1 min read

Meet Veristat at BIO-Europe Spring: March 23-25, 2026 - Lisbon, Portugal

Mar 23, 2026  Veristat Events

🔬 Connecting with the Global Biopharma Community

Veristat is pleased to attend BIO-Europe Spring, where biotech...

1 min read

Meet Veristat at PHUSE US Connect: Advancing Data-Driven Clinical Development

Mar 18, 2026  Veristat Events

🔬 Connecting with the Global Clinical Data and Biostatistics Community

Veristat is pleased to attend PHUSE US Connect...